Cargando…

Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis

Extensively drug-resistant tuberculosis (XDR TB) has extremely poor treatment outcomes in adults. Limited data are available for children. We report on clinical manifestations, treatment, and outcomes for 37 children (<15 years of age) with bacteriologically confirmed XDR TB in 11 countries. Thes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osman, Muhammad, Harausz, Elizabeth P., Garcia-Prats, Anthony J., Schaaf, H. Simon, Moore, Brittany K., Hicks, Robert M., Achar, Jay, Amanullah, Farhana, Barry, Pennan, Becerra, Mercedes, Chiotan, Domnica I., Drobac, Peter C., Flood, Jennifer, Furin, Jennifer, Gegia, Medea, Isaakidis, Petros, Mariandyshev, Andrei, Ozere, Iveta, Shah, N. Sarita, Skrahina, Alena, Yablokova, Elena, Seddon, James A., Hesseling, Anneke C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2019
Materias:	Synopsis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390755/ https://www.ncbi.nlm.nih.gov/pubmed/30789141 http://dx.doi.org/10.3201/eid2503.180852

Ejemplares similares

Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis
por: Harausz, Elizabeth P., et al.
Publicado: (2018)

Treatment of Rifampicin-Resistant Tuberculosis Disease and Infection in Children: Key Updates, Challenges and Opportunities
por: Howell, Pauline, et al.
Publicado: (2022)

Consensus Statement on Research Definitions for Drug-Resistant Tuberculosis in Children
por: Seddon, James A., et al.
Publicado: (2013)

Fluoroquinolone preventive therapy for children exposed to MDR-TB
por: Gureva, T., et al.
Publicado: (2022)

Risk factors for infection and disease in child contacts of multidrug-resistant tuberculosis: a cross-sectional study
por: Seddon, James A, et al.
Publicado: (2013)

Assessing the impact of multidrug-resistant tuberculosis in children: an exploratory qualitative study
por: Franck, Caroline, et al.
Publicado: (2014)

Assessing Complexity Among Patients With Tuberculosis in California, 1993–2016
por: Vaisman, Alon, et al.
Publicado: (2020)

Health insurance, healthcare utilization and language use among populations who experience risk for tuberculosis, California 2014–2017
por: Readhead, Adam, et al.
Publicado: (2022)

Tuberculosis Treatment Managed by Providers outside the Public Health Department: Lessons for the Affordable Care Act
por: Ehman, Melissa, et al.
Publicado: (2014)

1392. Tuberculosis Disease in Recipients of Organ-Transplantation, California 2010–2017
por: Katrak, Shereen, et al.
Publicado: (2019)

Association of Area-Based Socioeconomic Measures with Tuberculosis Incidence in California
por: Bakhsh, Yasser, et al.
Publicado: (2022)

Correction to: The impact of drug resistance on the risk of tuberculosis infection and disease in child household contacts: a cross sectional study
por: Golla, Vera, et al.
Publicado: (2017)

The impact of drug resistance on the risk of tuberculosis infection and disease in child household contacts: a cross sectional study
por: Golla, Vera, et al.
Publicado: (2017)

Injectable-free regimens containing bedaquiline, delamanid, or both for adolescents with rifampicin-resistant tuberculosis in Khayelitsha, South Africa
por: Mohr-Holland, Erika, et al.
Publicado: (2020)

Death With Tuberculosis in California, 1994–2008
por: Pascopella, Lisa, et al.
Publicado: (2014)

A systematic synthesis of direct costs to treat and manage tuberculosis disease applied to California, 2015
por: Oh, Peter, et al.
Publicado: (2017)

Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?
por: Benbaba, Stella, et al.
Publicado: (2015)

Making the Case for All-Oral, Shorter Regimens for Children with Drug-Resistant Tuberculosis
por: Patankar, Sayalee, et al.
Publicado: (2023)

Practical and psychosocial challenges faced by caregivers influence the acceptability of multidrug-resistant tuberculosis preventive therapy for young children
por: Wademan, Dillon T., et al.
Publicado: (2022)

Pediatric Tuberculosis Research and Development: Progress, Priorities and Funding Opportunities
por: McKenna, Lindsay, et al.
Publicado: (2022)

Toward a conceptual framework of the acceptability of tuberculosis treatment in children using a theory generative approach
por: Wademan, Dillon T., et al.
Publicado: (2022)

Getting to Zero: Tuberculosis Elimination in California
por: Barry, Pennan M., et al.
Publicado: (2016)

Tuberculosis: opportunities and challenges for the 90–90–90 targets in HIV-infected children
por: Rabie, Helena, et al.
Publicado: (2015)

Low-Dose Linezolid for Treatment of Patients With Multidrug-Resistant Tuberculosis
por: Mase, Anjeli, et al.
Publicado: (2022)

Pharmacokinetics and Drug-Drug Interactions of Abacavir and Lamuvudine Co-administered With Antituberculosis Drugs in HIV-Positive Children Treated for Multidrug-Resistant Tuberculosis
por: van der Laan, Louvina E., et al.
Publicado: (2021)

Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studies
por: Garcia-Prats, Anthony J., et al.
Publicado: (2019)

Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis
por: Achar, Jay, et al.
Publicado: (2017)

Tuberculosis Surveillance in Romania Among Vulnerable Risk Groups Between 2015 and 2017
por: Munteanu, Ioana, et al.
Publicado: (2022)

Tuberculosis Disease during Pregnancy and Treatment Outcomes in HIV-Infected and Uninfected Women at a Referral Hospital in Cape Town
por: Bekker, Adrie, et al.
Publicado: (2016)

Pharmacokinetics and optimized dosing of dispersible and non-dispersible levofloxacin formulations in young children
por: van der Laan, Louvina E, et al.
Publicado: (2023)

Tuberculous Meningitis in Children: A Forgotten Public Health Emergency
por: du Preez, Karen, et al.
Publicado: (2022)

Poor Outcomes in a Cohort of HIV-Infected Adolescents Undergoing Treatment for Multidrug-Resistant Tuberculosis in Mumbai, India
por: Isaakidis, Petros, et al.
Publicado: (2013)

Delamanid Added to an Optimized Background Regimen in Children with Multidrug-Resistant Tuberculosis: Results of a Phase I/II Clinical Trial
por: Garcia-Prats, Anthony J., et al.
Publicado: (2022)

Genotypic and phenotypic comparison of drug resistance profiles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing in Latvia
por: Vīksna, Anda, et al.
Publicado: (2023)

Pediatric tuberculosis: clinical and epidemiological reflections from a highly endemic setting
por: Hesseling, Anneke
Publicado: (2010)

Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP)
por: Seddon, James A., et al.
Publicado: (2018)

Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons
por: Gupta, Amita, et al.
Publicado: (2019)

Pneumonias – a dynamic relationship between the human organism and the etiologic agent
por: Chiotan, R, et al.
Publicado: (2014)

High Utility of Contact Investigation for Latent and Active Tuberculosis Case Detection among the Contacts: A Retrospective Cohort Study in Tbilisi, Georgia, 2010–2011
por: Chakhaia, Tsira, et al.
Publicado: (2014)

Optimising computer aided detection to identify intra-thoracic tuberculosis on chest x-ray in South African children
por: Palmer, Megan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t0sgk6cac74jl6frcg0ef82k6c